Home The Word Brain My Amedeo FAQ Privacy About   


As of September 2023, Amedeo had
10,218 active subscribers
with known affiliations


  Stroke

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 194 articles:
HTML format



Single Articles


    September 2023
  1. KI YJ, Han K, Kim HS, Han JK, et al
    Smoking and cardiovascular outcomes after percutaneous coronary intervention: a Korean study.
    Eur Heart J. 2023 Sep 26:ehad616. doi: 10.1093.
    PubMed     Abstract available


  2. ARDISSINO M, Morley AP, Slob EAW, Schuermans A, et al
    Birth weight influences cardiac structure, function, and disease risk: evidence of a causal association.
    Eur Heart J. 2023 Sep 20:ehad631. doi: 10.1093.
    PubMed     Abstract available


  3. MIDDELDORP ME, Sandhu RK
    The stroke enigma: decoding the sex risk factor in atrial fibrillation.
    Eur Heart J. 2023 Sep 6:ehad531. doi: 10.1093.
    PubMed    


    August 2023
  4. BUHARI H, Fang J, Han L, Austin PC, et al
    Stroke risk in women with atrial fibrillation.
    Eur Heart J. 2023 Aug 30:ehad508. doi: 10.1093.
    PubMed     Abstract available


  5. DICHGANS M, Faraci FM
    Brain endothelium: a nexus for cerebral small vessel disease.
    Eur Heart J. 2023 Aug 29:ehad526. doi: 10.1093.
    PubMed    


  6. GAUTIER A, Picard F, Ducrocq G, Elbez Y, et al
    New-onset atrial fibrillation in chronic coronary syndrome: the CLARIFY registry.
    Eur Heart J. 2023 Aug 27:ehad556. doi: 10.1093.
    PubMed     Abstract available


  7. WU J, Nadarajah R, Nakao YM, Nakao K, et al
    Temporal trends of cause-specific mortality after diagnosis of atrial fibrillation.
    Eur Heart J. 2023 Aug 25:ehad571. doi: 10.1093.
    PubMed     Abstract available


  8. BYRNE RA, Rossello X, Coughlan JJ, Barbato E, et al
    2023 ESC Guidelines for the management of acute coronary syndromes.
    Eur Heart J. 2023 Aug 25:ehad191. doi: 10.1093.
    PubMed    


  9. RAO S, Nazarzadeh M, Canoy D, Li Y, et al
    Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality.
    Eur Heart J. 2023 Aug 23:ehad535. doi: 10.1093.
    PubMed     Abstract available


  10. CREA F
    Antithrombotic treatment: personalized antiplatelet therapies and lessons from the gut microbiota.
    Eur Heart J. 2023;44:3023-3026.
    PubMed    


  11. SAMBOLA A, Lozano-Torres J, Boersma E, Olmos C, et al
    Predictors of embolism and death in left-sided infective endocarditis: the European Society of Cardiology EURObservational Research Programme European Infective Endocarditis registry.
    Eur Heart J. 2023 Aug 18:ehad507. doi: 10.1093.
    PubMed     Abstract available


  12. JOHANSEN MO, Afzal S, Vedel-Krogh S, Nielsen SF, et al
    From plasma triglycerides to triglyceride metabolism: effects on mortality in the Copenhagen General Population Study.
    Eur Heart J. 2023 Aug 14:ehad330. doi: 10.1093.
    PubMed     Abstract available


  13. PERSSON J, Yan J, Angeras O, Venetsanos D, et al
    PCI or CABG for left main coronary artery disease: the SWEDEHEART registry.
    Eur Heart J. 2023;44:2833-2842.
    PubMed     Abstract available


    July 2023
  14. CAMM AJ
    Should the risk of atrial fibrillation deter PFO closure for cryptogenic ischaemic stroke?
    Eur Heart J. 2023 Jul 21:ehad425. doi: 10.1093.
    PubMed    


  15. MENTE A, Dehghan M, Rangarajan S, O'Donnell M, et al
    Diet, cardiovascular disease, and mortality in 80 countries.
    Eur Heart J. 2023 Jul 6:ehad269. doi: 10.1093.
    PubMed     Abstract available


    June 2023
  16. YANG M, Kondo T, Butt JH, Abraham WT, et al
    Stroke in patients with heart failure and reduced or preserved ejection fraction.
    Eur Heart J. 2023 Jun 26:ehad338. doi: 10.1093.
    PubMed     Abstract available


  17. WITSCH J, Kasner SE
    Redefining the role of heart failure in stroke.
    Eur Heart J. 2023 Jun 26:ehad360. doi: 10.1093.
    PubMed    


  18. BOERHOUT CKM, Lee JM, de Waard GA, Mejia-Renteria H, et al
    Microvascular resistance reserve: diagnostic and prognostic performance in the ILIAS registry.
    Eur Heart J. 2023 Jun 23:ehad378. doi: 10.1093.
    PubMed     Abstract available


  19. KALKMAN DN, Couturier EGM, El Bouziani A, Dahdal J, et al
    Migraine and cardiovascular disease: what cardiologists should know.
    Eur Heart J. 2023 Jun 22:ehad363. doi: 10.1093.
    PubMed     Abstract available


  20. NEMET I, Li XS, Haghikia A, Li L, et al
    Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality.
    Eur Heart J. 2023 Jun 21:ehad333. doi: 10.1093.
    PubMed     Abstract available


  21. SKIBSTED CV, Korsholm K, Pedersen L, Bonnesen K, et al
    Long-term risk of atrial fibrillation or flutter after transcatheter patent foramen ovale closure: a nationwide Danish study.
    Eur Heart J. 2023 Jun 3:ehad305. doi: 10.1093.
    PubMed     Abstract available


  22. CHO JY, Kim KH, Lee N, Cho SH, et al
    COVID-19 vaccination-related myocarditis: a Korean nationwide study.
    Eur Heart J. 2023 Jun 2:ehad339. doi: 10.1093.
    PubMed     Abstract available


  23. SCHMIDT LE, Speidl WS, Tsimikas S, Mayr M, et al
    Reducing reductionism: addressing risk for atherosclerotic cardiovascular disease by apolipoprotein proteomics.
    Eur Heart J. 2023 Jun 2:ehad294. doi: 10.1093.
    PubMed    


    May 2023

  24. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe.
    Eur Heart J. 2023 May 29:ehad260. doi: 10.1093.
    PubMed     Abstract available


  25. CHENG Z, Pu J, Wu W
    Closure of patent foramen ovale after surgery with atrial septal defect occluder accompanied by Marfan syndrome.
    Eur Heart J. 2023;44:1840.
    PubMed    


  26. CREA F
    Thrombotic and bleeding complications during antithrombotic treatment: the need for new therapeutic targets.
    Eur Heart J. 2023;44:1767-1770.
    PubMed    


  27. ZANNAD F, Crea F, Keaney J, Spencer S, et al
    Rapid, accurate publication and dissemination of clinical trial results: benefits and challenges.
    Eur Heart J. 2023 May 11:ehad279. doi: 10.1093.
    PubMed     Abstract available


    April 2023
  28. EL BAOU C, Desai R, Cooper C, Marchant NL, et al
    Psychological therapies for depression and cardiovascular risk: evidence from national healthcare records in England.
    Eur Heart J. 2023 Apr 18:ehad188. doi: 10.1093.
    PubMed     Abstract available


  29. JALLOH MB, Granger CB, Fonarow GC, Van Spall HGC, et al
    Multi-level implementation strategies to improve uptake of evidence-based therapies in heart failure.
    Eur Heart J. 2023 Apr 15:ehad150. doi: 10.1093.
    PubMed    


  30. HAEUSLER KG
    Ischaemic stroke in atrial fibrillation patients while on oral anticoagulation-a call for A-C-T-I-O-N.
    Eur Heart J. 2023 Apr 11:ehad203. doi: 10.1093.
    PubMed    


  31. BENZ AP, Hohnloser SH, Eikelboom JW, Carnicelli AP, et al
    Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation.
    Eur Heart J. 2023 Apr 11:ehad200. doi: 10.1093.
    PubMed     Abstract available


  32. CHEN HY, Dina C, Small AM, Shaffer CM, et al
    Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study.
    Eur Heart J. 2023 Apr 11:ehad142. doi: 10.1093.
    PubMed     Abstract available


  33. CREA F
    Focus issue on vascular biology and medicine spanning from management of stroke to new therapeutic targets in aortic dissection and pulmonary hypertension.
    Eur Heart J. 2023;44:1193-1196.
    PubMed    


    March 2023
  34. NURMOHAMED NS, Kraaijenhof JM, Mayr M, Nicholls SJ, et al
    Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction.
    Eur Heart J. 2023 Mar 29:ehad161. doi: 10.1093.
    PubMed     Abstract available


  35. SIEDLINSKI M, Carnevale L, Xu X, Carnevale D, et al
    Genetic analyses identify brain structures related to cognitive impairment associated with elevated blood pressure.
    Eur Heart J. 2023 Mar 27:ehad101. doi: 10.1093.
    PubMed     Abstract available


  36. BUTT JH, Petrie MC, Jhund PS, Sattar N, et al
    Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox.
    Eur Heart J. 2023 Mar 22:ehad083. doi: 10.1093.
    PubMed     Abstract available


  37. VERWERFT J, Soens L, Wynants J, Meysman M, et al
    Heart failure with preserved ejection fraction: relevance of a dedicated dyspnoea clinic.
    Eur Heart J. 2023 Mar 16:ehad141. doi: 10.1093.
    PubMed     Abstract available


  38. KLOK FA, Pruszczyk P, Konstantinides SV
    Thrombolytic treatment of life-threatening pulmonary embolism in times of alteplase shortage.
    Eur Heart J. 2023 Mar 14:ehad120. doi: 10.1093.
    PubMed    


  39. LUND LH, Hage C, Pironti G, Thorvaldsen T, et al
    Acyl ghrelin improves cardiac function in heart failure and increases fractional shortening in cardiomyocytes without calcium mobilization.
    Eur Heart J. 2023 Mar 14:ehad100. doi: 10.1093.
    PubMed     Abstract available


  40. JIANG Y, Huang J, Li G, Wang W, et al
    Ozone pollution and hospital admissions for cardiovascular events.
    Eur Heart J. 2023 Mar 10:ehad091. doi: 10.1093.
    PubMed     Abstract available


  41. CHIPAYO-GONZALES D, Salinas P, Viana-Tejedor A
    Successful aspiration of an iatrogenic clot in transit secondary to a failed mechanical thrombectomy in pulmonary embolism.
    Eur Heart J. 2023 Mar 8:ehad095. doi: 10.1093.
    PubMed    


  42. SHEMESH E, Chevli PA, Islam T, German CA, et al
    Circulating ketone bodies and cardiovascular outcomes: the MESA study.
    Eur Heart J. 2023 Mar 6:ehad087. doi: 10.1093.
    PubMed     Abstract available


  43. LEE SH, Kim HK, Ahn JH, Kang MG, et al
    Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction.
    Eur Heart J. 2023 Mar 1:ehad088. doi: 10.1093.
    PubMed     Abstract available


  44. MAJMUNDAR M, Doshi R, Patel KN, Zala H, et al
    Prevalence, trends, and outcomes of cardiovascular diseases in pregnant patients in the USA: 2010-19.
    Eur Heart J. 2023;44:726-737.
    PubMed     Abstract available


    January 2023
  45. GAUDINO M, Di Franco A, Rong LQ, Piccini J, et al
    Postoperative atrial fibrillation: from mechanisms to treatment.
    Eur Heart J. 2023 Jan 31:ehad019. doi: 10.1093.
    PubMed     Abstract available


  46. MARK PB, Carrero JJ, Matsushita K, Sang Y, et al
    Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study.
    Eur Heart J. 2023 Jan 24:ehac825. doi: 10.1093.
    PubMed     Abstract available


  47. CREA F
    Ischaemic heart disease: antithrombotic treatment and new therapeutic targets.
    Eur Heart J. 2023;44:239-242.
    PubMed    


  48. KATO ET, Morrow DA, Guo J, Berg DD, et al
    Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
    Eur Heart J. 2023;44:293-300.
    PubMed     Abstract available


  49. AHMAD Y, Howard JP, Arnold AD, Madhavan MV, et al
    Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials.
    Eur Heart J. 2023 Jan 20:ehac642. doi: 10.1093.
    PubMed     Abstract available


  50. RAY KK, Raal FJ, Kallend DG, Jaros MJ, et al
    Inclisiran and cardiovascular events: a patient-level analysis of phase III trials.
    Eur Heart J. 2023;44:129-138.
    PubMed     Abstract available


    December 2022
  51. DOVE A, Guo J, Marseglia A, Fastbom J, et al
    Cardiometabolic multimorbidity and incident dementia: the Swedish twin registry.
    Eur Heart J. 2022 Dec 29:ehac744. doi: 10.1093.
    PubMed     Abstract available


  52. PETERS R, Xu Y, Fitzgerald O, Aung HL, et al
    Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis.
    Eur Heart J. 2022;43:4980-4990.
    PubMed     Abstract available


  53. LEE JM, Kim HK, Park KH, Choo EH, et al
    Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial.
    Eur Heart J. 2022 Dec 20:ehac763. doi: 10.1093.
    PubMed     Abstract available


  54. DAVIDSON JA, Banerjee A, Douglas I, Leyrat C, et al
    Primary prevention of acute cardiovascular events by influenza vaccination: an observational study.
    Eur Heart J. 2022 Dec 20:ehac737. doi: 10.1093.
    PubMed     Abstract available


  55. DAVIDSON JA, Banerjee A, Douglas I, Leyrat C, et al
    Primary prevention of acute cardiovascular events by influenza vaccination: an observational study.
    Eur Heart J. 2022 Dec 20:ehac737. doi: 10.1093.
    PubMed     Abstract available


  56. LEE YJ, Cho JY, You SC, Lee YH, et al
    Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial.
    Eur Heart J. 2022 Dec 19:ehac709. doi: 10.1093.
    PubMed     Abstract available


  57. LEE YJ, Cho JY, You SC, Lee YH, et al
    Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial.
    Eur Heart J. 2022 Dec 19:ehac709. doi: 10.1093.
    PubMed     Abstract available


  58. LIUZZO G, Patrono C
    Vitamin K antagonists remain the INVICTUS standard of care for patients with rheumatic heart disease and atrial fibrillation.
    Eur Heart J. 2022 Dec 17:ehac721. doi: 10.1093.
    PubMed    


  59. O'SULLIVAN JW, Ashley EA, Elliott PM
    Polygenic risk scores for the prediction of cardiometabolic disease.
    Eur Heart J. 2022 Dec 7:ehac648. doi: 10.1093.
    PubMed     Abstract available


  60. WIDIMSKY P, Snyder K, Sulzenko J, Hopkins LN, et al
    Acute ischaemic stroke: recent advances in reperfusion treatment.
    Eur Heart J. 2022 Dec 7:ehac684. doi: 10.1093.
    PubMed     Abstract available


  61. ANDREOTTI F, Geisler T, Collet JP, Gigante B, et al
    Acute, periprocedural and longterm antithrombotic therapy in older adults.
    Eur Heart J. 2022 Dec 7:ehac515. doi: 10.1093.
    PubMed     Abstract available


  62. EL-CHOULI M, Meddis A, Christensen DM, Gerds TA, et al
    Lifetime risk of comorbidity in patients with simple congenital heart disease: a Danish nationwide study.
    Eur Heart J. 2022 Dec 7:ehac727. doi: 10.1093.
    PubMed     Abstract available


  63. COSTA F, Montalto C, Branca M, Hong SJ, et al
    Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.
    Eur Heart J. 2022 Dec 7:ehac706. doi: 10.1093.
    PubMed     Abstract available


  64. LIBERALE L, Puspitasari YM, Ministrini S, Akhmedov A, et al
    JCAD promotes arterial thrombosis through PI3K/Akt modulation: a translational study.
    Eur Heart J. 2022 Dec 5:ehac641. doi: 10.1093.
    PubMed     Abstract available


  65. ANDRADE JG, Deyell MW, Macle L, Steinberg JS, et al
    Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study.
    Eur Heart J. 2022 Dec 2:ehac692. doi: 10.1093.
    PubMed     Abstract available


  66. SPATZ ES, Herrin J
    Screening for atrial fibrillation to prevent stroke: increasing enthusiasm but outcomes still lag.
    Eur Heart J. 2022 Dec 2:ehac696. doi: 10.1093.
    PubMed    


  67. OSMANCIK P, Widimsky P
    Left atrial appendage occluders-new hope for stroke prevention in high-risk patients.
    Eur Heart J. 2022;43:4669-4671.
    PubMed    


    November 2022
  68. SINNER MF, von Falkenhausen AS
    A specific new biomarker for atrial fibrillation and its sequelae?
    Eur Heart J. 2022 Nov 18. pii: 6833208. doi: 10.1093.
    PubMed    


  69. HIJAZI Z, Benz AP, Lindback J, Alexander JH, et al
    Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation.
    Eur Heart J. 2022 Nov 16. pii: 6830621. doi: 10.1093.
    PubMed     Abstract available


  70. BONACA MP, Im K, Magnani G, Bansilal S, et al
    Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
    Eur Heart J. 2022 Nov 11. pii: 6823782. doi: 10.1093.
    PubMed     Abstract available


  71. LYTH J, Svennberg E, Bernfort L, Aronsson M, et al
    Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study.
    Eur Heart J. 2022 Nov 9. pii: 6806218. doi: 10.1093.
    PubMed     Abstract available


  72. LAUDER L, Mahfoud F, Azizi M, Bhatt DL, et al
    Hypertension management in patients with cardiovascular comorbidities.
    Eur Heart J. 2022 Nov 7. pii: 6808663. doi: 10.1093.
    PubMed     Abstract available


  73. FONSECA HAR, Furtado RHM, Zimerman A, Lemos PA, et al
    Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial.
    Eur Heart J. 2022;43:4378-4388.
    PubMed     Abstract available


    October 2022
  74. MEYRE PB, Blum S, Hennings E, Aeschbacher S, et al
    Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing.
    Eur Heart J. 2022 Oct 26. pii: 6773770. doi: 10.1093.
    PubMed     Abstract available


  75. XIAO Q, Pu X, Wei X, Chen M, et al
    Refractory cardiogenic shock in a senile atrial fibrillation patient after left atrial appendage occlusion.
    Eur Heart J. 2022 Oct 17. pii: 6761762. doi: 10.1093.
    PubMed    


  76. TARDIF JC, Pfeffer MA, Kouz S, Koenig W, et al
    Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial.
    Eur Heart J. 2022;43:3947-3956.
    PubMed     Abstract available


  77. ZHOU WX, Tang H, Wei X
    Identifies culprit of cerebral infarction: contrast echocardiography of right heart through uncommon route.
    Eur Heart J. 2022;43:3813.
    PubMed    


    September 2022
  78. VAN DEN ENDEN AJM, Meuwese CL, Van Mieghem NM
    Changing biventricular mechanics during thrombectomy for intermediate high-risk pulmonary embolism.
    Eur Heart J. 2022 Sep 21. pii: 6710213. doi: 10.1093.
    PubMed    


  79. MESSERLI FH, O'Donnell M, Mente A, Yusuf S, et al
    Settling the controversy of salt substitutes and stroke: sodium reduction or potassium increase?
    Eur Heart J. 2022;43:3365-3367.
    PubMed    


  80. HESS CN, Bonaca MP
    Risk of remnants and remnant risk in peripheral artery disease.
    Eur Heart J. 2022;43:3270-3272.
    PubMed    


  81. KITE TA, Kurmani SA, Bountziouka V, Cooper NJ, et al
    Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials.
    Eur Heart J. 2022;43:3148-3161.
    PubMed     Abstract available


    August 2022
  82. KRONENBERG F, Mora S, Stroes ESG, Ference BA, et al
    Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.
    Eur Heart J. 2022 Aug 29. pii: 6670882. doi: 10.1093.
    PubMed     Abstract available


  83. ECKARDT L, Sehner S, Suling A, Borof K, et al
    Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST - AFNET 4 trial.
    Eur Heart J. 2022 Aug 29. pii: 6675568. doi: 10.1093.
    PubMed     Abstract available


  84. KONDO T, Abdul-Rahim AH, Talebi A, Abraham WT, et al
    Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
    Eur Heart J. 2022 Aug 26. pii: 6676501. doi: 10.1093.
    PubMed     Abstract available


  85. SAGRIS D, Shantsila E, Lip GYH
    Stroke risk stratification in patients with heart failure and sinus rhythm.
    Eur Heart J. 2022 Aug 26. pii: 6676507. doi: 10.1093.
    PubMed    


  86. HUQI A, Zoccali C, Giugliano RP, De Caterina R, et al
    Safety of non-vitamin K antagonist oral anticoagulants: concerns in patients with atrial fibrillation and glomerular hyperfiltration?
    Eur Heart J. 2022 Aug 19. pii: 6671685. doi: 10.1093.
    PubMed    


  87. VOLPE M, Patrono C
    One-shot thrombolysis for the management of acute ischaemic stroke.
    Eur Heart J. 2022 Aug 18. pii: 6670981. doi: 10.1093.
    PubMed    


    July 2022
  88. LIP GYH, Lane DA, Lenarczyk R, Boriani G, et al
    Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke.
    Eur Heart J. 2022;43:2442-2460.
    PubMed     Abstract available


  89. BLANC-VANNET S, Vautrin E, Piliero N
    Massive device thrombosis, multiple embolisms, and delayed-onset heparin-induced thrombocytopenia: a rare but severe complication of patent foramen ovale closure.
    Eur Heart J. 2022;43:2425.
    PubMed    


    May 2022
  90. VAN VELDHUISEN SL, Gorter TM, van Woerden G, de Boer RA, et al
    Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1955-1969.
    PubMed     Abstract available


  91. COLLET JP, Van Belle E, Thiele H, Berti S, et al
    Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
    Eur Heart J. 2022 May 18. pii: 6587401. doi: 10.1093.
    PubMed     Abstract available


  92. VALGIMIGLI M, Smits PC, Frigoli E, Bongiovanni D, et al
    Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.
    Eur Heart J. 2022 May 17. pii: 6587125. doi: 10.1093.
    PubMed     Abstract available


  93. KANY S, Metzner A, Lubos E, Kirchhof P, et al
    The Atrial Fibrillation Heart Team-guiding therapy in left atrial appendage occlusion with increasingly complex patients and little evidence.
    Eur Heart J. 2022;43:1691-1692.
    PubMed    


  94. HAGEMAN SHJ, McKay AJ, Ueda P, Gunn LH, et al
    Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
    Eur Heart J. 2022;43:1715-1727.
    PubMed     Abstract available


    April 2022
  95. HONG S, Kim KS, Han K, Park CY, et al
    Acromegaly and cardiovascular outcomes: a cohort study.
    Eur Heart J. 2022;43:1491-1499.
    PubMed     Abstract available


    March 2022
  96. KOMEN JJ, Pottegard A, Mantel-Teeuwisse AK, Forslund T, et al
    Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study.
    Eur Heart J. 2022 Mar 10. pii: 6546013. doi: 10.1093.
    PubMed     Abstract available


  97. MCINTYRE WF, Linz D
    Atrial fibrillation and stroke: who is low risk and what are we going to do about it?
    Eur Heart J. 2022 Mar 10. pii: 6546014. doi: 10.1093.
    PubMed    


    February 2022
  98. ROSSI A, Mikail N, Bengs S, Haider A, et al
    Heart-brain interactions in cardiac and brain diseases: why sex matters.
    Eur Heart J. 2022 Feb 23. pii: 6534632. doi: 10.1093.
    PubMed     Abstract available


  99. SHRAUNER W, Lord EM, Nguyen XT, Song RJ, et al
    Frailty and cardiovascular mortality in more than 3 million US Veterans.
    Eur Heart J. 2022;43:818-826.
    PubMed     Abstract available


  100. JARED BUNCH T, Steinberg BA
    Clinical strokes in atrial fibrillation: the tip of the iceberg.
    Eur Heart J. 2022 Feb 18. pii: 6532261. doi: 10.1093.
    PubMed    


  101. KUHNE M, Krisai P, Coslovsky M, Rodondi N, et al
    Silent brain infarcts impact on cognitive function in atrial fibrillation.
    Eur Heart J. 2022 Feb 17. pii: 6529516. doi: 10.1093.
    PubMed     Abstract available


  102. COSEMANS JMEM
    Platelet-derived MMP-2 in the prevention of plaque formation: how many strokes is par?
    Eur Heart J. 2022;43:515-517.
    PubMed    


  103. NURMOHAMED NS, Belo Pereira JP, Hoogeveen RM, Kroon J, et al
    Targeted proteomics improves cardiovascular risk prediction in secondary prevention.
    Eur Heart J. 2022 Feb 9. pii: 6525629. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  104. NARDUCCI ML, Volpe M
    Implantable recorders and systematic atrial fibrillation detection do not outperform standard of care in stroke prevention in the LOOP study.
    Eur Heart J. 2022;43:261-262.
    PubMed    


  105. NOUBIAP JJ
    The association of atrial fibrillation with mortality in patients with breast cancer.
    Eur Heart J. 2022 Jan 28. pii: 6516864. doi: 10.1093.
    PubMed    


  106. WEGENER S
    Triggers of stroke: anger, emotional upset, and heavy physical exertion. New insights from the INTERSTROKE study.
    Eur Heart J. 2022;43:210-212.
    PubMed    


  107. NICHOLLS M
    Preventing stroke in atrial fibrillation patients.
    Eur Heart J. 2022 Jan 25. pii: 6515302. doi: 10.1093.
    PubMed    


  108. LEHTISALO J, Rusanen M, Solomon A, Antikainen R, et al
    Effect of a multi-domain lifestyle intervention on cardiovascular risk in older people: the FINGER trial.
    Eur Heart J. 2022 Jan 20. pii: 6512207. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  109. LABORI F, Persson J, Bonander C, Jood K, et al
    Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation.
    Eur Heart J. 2021 Dec 17. pii: 6468857. doi: 10.1093.
    PubMed     Abstract available


  110. GALLI M, Benenati S, Franchi F, Rollini F, et al
    Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
    Eur Heart J. 2021 Dec 16. pii: 6464193. doi: 10.1093.
    PubMed     Abstract available


  111. KLOK FA, Ageno W, Ay C, Back M, et al
    Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on A
    Eur Heart J. 2021 Dec 7. pii: 6454843. doi: 10.1093.
    PubMed     Abstract available


  112. SMYTH A, O'Donnell M, Hankey GJ, Rangarajan S, et al
    Anger or emotional upset and heavy physical exertion as triggers of stroke: the INTERSTROKE study.
    Eur Heart J. 2021 Dec 1. pii: 6447061. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  113. GASBARRINO K, Di Iorio D, Daskalopoulou SS
    Importance of sex and gender in ischaemic stroke and carotid atherosclerotic disease.
    Eur Heart J. 2021 Nov 26. pii: 6444192. doi: 10.1093.
    PubMed     Abstract available


  114. CAMEN S, Schnabel RB
    Genetics, atrial cardiomyopathy, and stroke: enough components for a sufficient cause?
    Eur Heart J. 2021;42:4533-4535.
    PubMed    


  115. MARAZITI G, Vinson DR, Becattini C
    Echocardiography for risk stratification in patients with pulmonary embolism at low risk of death: a response.
    Eur Heart J. 2021 Nov 11. pii: 6425623. doi: 10.1093.
    PubMed    


    October 2021
  116. FEDOROWSKI A, Siller-Matula JM, Patti G
    Thrombosis and fibrinolysis in atherosclerotic cardiovascular disease: it takes two to tango.
    Eur Heart J. 2021 Oct 23. pii: 6408927. doi: 10.1093.
    PubMed    


  117. ESCANED J, Cao D, Baber U, Nicolas J, et al
    Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
    Eur Heart J. 2021 Oct 18. pii: 6400337. doi: 10.1093.
    PubMed     Abstract available


  118. WADSTROM BN, Wulff AB, Pedersen KM, Jensen GB, et al
    Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study.
    Eur Heart J. 2021 Oct 18. pii: 6399975. doi: 10.1093.
    PubMed     Abstract available


  119. LUSCHER TF, Davies A, Beer JH, Valgimigli M, et al
    Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum.
    Eur Heart J. 2021 Oct 8. pii: 6384672. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  120. RUSSO AM
    Alcohol intake and risk of stroke in atrial fibrillation: the lesser the better, but this is not enough.
    Eur Heart J. 2021 Sep 30. pii: 6378270. doi: 10.1093.
    PubMed    


  121. SPOSATO LA, Aspberg S, Scheitz JF, Fisher M, et al
    The World Stroke Organization Brain & Heart Task Force: collaborations between stroke physicians and cardiologists.
    Eur Heart J. 2021;42:3594-3596.
    PubMed    


  122. OYAMA K, Giugliano RP, Tang M, Bonaca MP, et al
    Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial.
    Eur Heart J. 2021 Sep 19. pii: 6372436. doi: 10.1093.
    PubMed     Abstract available


  123. LOPEZ-SENDON JL, Cyr DD, Mark DB, Bangalore S, et al
    Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
    Eur Heart J. 2021 Sep 13. pii: 6368943. doi: 10.1093.
    PubMed     Abstract available


  124. DEFILIPPIS AP, Trainor PJ, Thanassoulis G, Brumback LC, et al
    Atherothrombotic factors and atherosclerotic cardiovascular events: the multi-ethnic study of atherosclerosis.
    Eur Heart J. 2021 Sep 11. pii: 6368900. doi: 10.1093.
    PubMed     Abstract available


  125. KANG EH, Park EH, Shin A, Song JS, et al
    Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout.
    Eur Heart J. 2021 Sep 11. pii: 6368678. doi: 10.1093.
    PubMed     Abstract available


  126. PETERSEN JK, Haider Butt J, Yafasova A, Torp-Pedersen C, et al
    Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
    Eur Heart J. 2021 Sep 3. pii: 6363625. doi: 10.1093.
    PubMed     Abstract available


  127. GINSBERG HN, Packard CJ, Chapman MJ, Boren J, et al
    Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.
    Eur Heart J. 2021 Sep 2. pii: 6362485. doi: 10.1093.
    PubMed     Abstract available


  128. BONNESEN MP, Frodi DM, Haugan KJ, Kronborg C, et al
    Day-to-day measurement of physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 Sep 2. pii: 6362464. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  129. WILLEMS S, Borof K, Brandes A, Breithardt G, et al
    Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial.
    Eur Heart J. 2021 Aug 27. pii: 6358078. doi: 10.1093.
    PubMed     Abstract available


  130. KRANTZ MJ, Debus SE, Hsia J, Patel MR, et al
    Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.
    Eur Heart J. 2021 Aug 25. pii: 6357238. doi: 10.1093.
    PubMed     Abstract available


  131. STEFANINI GG, Briguori C, Cao D, Baber U, et al
    Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
    Eur Heart J. 2021 Aug 23. pii: 6356261. doi: 10.1093.
    PubMed     Abstract available


  132. YOUNG KA, Bonnichsen CR
    Left ventricular pseudoaneurysm as source of recurrent stroke.
    Eur Heart J. 2021;42:3106.
    PubMed    


  133. ZEYMER U, Ludman P, Danchin N, Kala P, et al
    Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology.
    Eur Heart J. 2021 Aug 14. pii: 6352178. doi: 10.1093.
    PubMed     Abstract available


  134. BECATTINI C, Cimini LA, Agnelli G
    Home management or hospital admission for low-risk pulmonary embolism? Clinical scores versus pragmatic assessment.
    Eur Heart J. 2021 Aug 13. pii: 6350777. doi: 10.1093.
    PubMed    


  135. GAUDINO M, Di Franco A, Alexander JH, Bakaeen F, et al
    Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data.
    Eur Heart J. 2021 Aug 2. pii: 6333765. doi: 10.1093.
    PubMed     Abstract available


  136. HAN Y, Hu Y, Yu C, Guo Y, et al
    Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study.
    Eur Heart J. 2021 Aug 1. pii: 6333295. doi: 10.1093.
    PubMed     Abstract available


  137. ROMITI GF, Corica B, Pipitone E, Vitolo M, et al
    Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
    Eur Heart J. 2021 Aug 1. pii: 6333297. doi: 10.1093.
    PubMed     Abstract available


  138. KIM MS, Kim WJ, Khera AV, Kim JY, et al
    Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies.
    Eur Heart J. 2021 Aug 1. pii: 6333298. doi: 10.1093.
    PubMed     Abstract available


  139. REIFFEL JA
    When two is not better than one: the amalgamation of atrial fibrillation and chronic obstructive pulmonary disease.
    Eur Heart J. 2021 Aug 1. pii: 6333293. doi: 10.1093.
    PubMed    


    July 2021
  140. KOSYAKOVSKY LB, Austin PC, Ross HJ, Wang X, et al
    Early invasive coronary angiography and acute ischaemic heart failure outcomes.
    Eur Heart J. 2021 Jul 30. pii: 6331345. doi: 10.1093.
    PubMed     Abstract available


  141. TOOROP MMA, Chen Q, Tichelaar VYIG, Cannegieter SC, et al
    Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
    Eur Heart J. 2021 Jul 16. pii: 6322389. doi: 10.1093.
    PubMed     Abstract available



  142. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.
    Eur Heart J. 2021;42:2455-2467.
    PubMed     Abstract available


    June 2021
  143. BECATTINI C, Maraziti G, Vinson DR, Ng ACC, et al
    Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis.
    Eur Heart J. 2021 Jun 28. pii: 6310284. doi: 10.1093.
    PubMed     Abstract available


  144. HE FJ, Campbell NRC, Woodward M, MacGregor GA, et al
    Salt reduction to prevent hypertension: the reasons of the controversy.
    Eur Heart J. 2021 Jun 12. pii: 6297147. doi: 10.1093.
    PubMed     Abstract available


  145. LEE SR, Choi EK, Jung JH, Han KD, et al
    Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study.
    Eur Heart J. 2021 Jun 7. pii: 6294435. doi: 10.1093.
    PubMed     Abstract available


  146. CREA F
    Dyslipidaemias in stroke, chronic kidney disease, and aortic stenosis: the new frontiers for cholesterol lowering.
    Eur Heart J. 2021;42:2137-2140.
    PubMed    


  147. TSIMIKAS S
    Elevated lipoprotein(a) and the risk of stroke in children, young adults, and the elderly.
    Eur Heart J. 2021;42:2197-2200.
    PubMed    


    May 2021
  148. KHURSHID S, Weng LC, Al-Alusi MA, Halford JL, et al
    Accelerometer-derived physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 May 25. pii: 6283622. doi: 10.1093.
    PubMed     Abstract available


  149. LANSKY AJ, Makkar R, Nazif T, Messe S, et al
    A randomized evaluation of the TriGuard HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.
    Eur Heart J. 2021 May 17. pii: 6277114. doi: 10.1093.
    PubMed     Abstract available


  150. CREA F
    New challenges in vascular biology and medicine: from unravelling the mechanisms of neointima formation to the prevention of amputations and of ischaemic stroke.
    Eur Heart J. 2021;42:1715-1719.
    PubMed    


  151. IMAZIO M, Nidorf M
    Colchicine and the heart.
    Eur Heart J. 2021 May 7. pii: 6271392. doi: 10.1093.
    PubMed     Abstract available


  152. KROHN-GRIMBERGHE M, Duerschmied D, Bode C
    What do we learn by repeating the ABC?
    Eur Heart J. 2021;42:1707-1709.
    PubMed    


    April 2021
  153. BRIEGER D, Freedman B
    Decoding stroke risk scores in atrial fibrillation: still more work to do.
    Eur Heart J. 2021 Apr 6. pii: 6213361. doi: 10.1093/eurheartj/ehaa1111.
    PubMed    


    March 2021
  154. DE JONG Y, Fu EL, van Diepen M, Trevisan M, et al
    Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrum of kidney function.
    Eur Heart J. 2021 Mar 26. pii: 6188994. doi: 10.1093.
    PubMed     Abstract available


  155. FIOLET ATL, Opstal TSJ, Mosterd A, Eikelboom JW, et al
    Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
    Eur Heart J. 2021 Mar 26. pii: 6188997. doi: 10.1093.
    PubMed     Abstract available


  156. AJJAN RA, Kietsiriroje N, Badimon L, Vilahur G, et al
    Antithrombotic therapy in diabetes: which, when, and for how long?
    Eur Heart J. 2021 Mar 25. pii: 6186730. doi: 10.1093.
    PubMed     Abstract available


  157. OYAMA K, Giugliano RP, Berg DD, Ruff CT, et al
    Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
    Eur Heart J. 2021 Mar 24. pii: 6184829. doi: 10.1093.
    PubMed     Abstract available


  158. ARNOLD M, Schweizer J, Nakas CT, Schutz V, et al
    Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study.
    Eur Heart J. 2021 Mar 8. pii: 6168588. doi: 10.1093.
    PubMed     Abstract available


  159. REED GW, Krishnaswamy A, Kapadia SR
    Silent brain infarction after TAVR: common but of unclear significance.
    Eur Heart J. 2021;42:1016-1018.
    PubMed    


    February 2021
  160. BUTT JH, Fosbol EL, Gerds TA, Andersson C, et al
    All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study.
    Eur Heart J. 2021 Feb 24. pii: 6149000. doi: 10.1093.
    PubMed     Abstract available


  161. WOLDENDORP K, Indja B, Bannon PG, Fanning JP, et al
    Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.
    Eur Heart J. 2021 Feb 1. pii: 6124789. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  162. SEMERANO A, Saliou G, Sanvito F, Genchi A, et al
    Fishing an anemone in the brain: embolized cardiac fibroelastoma revealed after stroke thrombectomy.
    Eur Heart J. 2021 Jan 31. pii: 6124843. doi: 10.1093.
    PubMed    


  163. PRISTIPINO C, Germonpre P, Toni D, Sievert H, et al
    European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions.
    Eur Heart J. 2021 Jan 28. pii: 6122426. doi: 10.1093/eurheartj/ehaa1070.
    PubMed     Abstract available


  164. RIENSTRA M, Van Gelder IC
    Incidence and outcome of atrial fibrillation: diversity throughout Europe.
    Eur Heart J. 2021 Jan 25. pii: 6120041. doi: 10.1093/eurheartj/ehaa1078.
    PubMed    



  165. Corrigendum to: Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment: Position Paper from the ESC Council on Stroke and the European Association for Percutaneous Cardiovascula
    Eur Heart J. 2021;42:307.
    PubMed    


  166. NARDAI S, Lanzer P, Abelson M, Baumbach A, et al
    Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment: Position Paper from the ESC Council on Stroke and the European Association for Percutaneous Cardiovascular Interventions
    Eur Heart J. 2021;42:298-307.
    PubMed     Abstract available


  167. CREA F
    Management of ischaemic stroke, prognostic impact of procedural myocardial injury, and antiplatelet treatment: the many facets of interventional cardiology.
    Eur Heart J. 2021;42:289-291.
    PubMed    


    December 2020
  168. SCHUBERT J, Lindahl B, Melhus H, Renlund H, et al
    Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study.
    Eur Heart J. 2020 Dec 24. pii: 6047259. doi: 10.1093/eurheartj/ehaa1011.
    PubMed     Abstract available


  169. PETERMANN-ROCHA F, Parra-Soto S, Gray S, Anderson J, et al
    Vegetarians, fish, poultry, and meat-eaters: who has higher risk of cardiovascular disease incidence and mortality? A prospective study from UK Biobank.
    Eur Heart J. 2020 Dec 14. pii: 6032616. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  170. NARDAI S, Lanzer P, Abelson M, Baumbach A, et al
    Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment.
    Eur Heart J. 2020 Nov 7. pii: 5960214. doi: 10.1093.
    PubMed     Abstract available


  171. NANJO A, Evans H, Direk K, Hayward AC, et al
    Prevalence, incidence, and outcomes across cardiovascular diseases in homeless individuals using national linked electronic health records.
    Eur Heart J. 2020;41:4011-4020.
    PubMed     Abstract available


    October 2020
  172. LIUZZO G, Patrono C
    Low-Dose Edoxaban for Stroke Prevention in Elderly Patients with Atrial Fibrillation: Comment on the Edoxaban Low-Dose for Elder Care Atrial Fibrillation Patients (ELDERCARE-AF) Trial.
    Eur Heart J. 2020 Oct 17. pii: 5927543. doi: 10.1093.
    PubMed    


    September 2020
  173. WALLENTIN L, Lindback J, Eriksson N, Hijazi Z, et al
    Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
    Eur Heart J. 2020 Sep 27. pii: 5912214. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  174. VRANCKX P, Valgimigli M, Eckardt L, Lewalter T, et al
    Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.
    Eur Heart J. 2020 Aug 29. pii: 5898835. doi: 10.1093.
    PubMed     Abstract available


  175. BOUABDALLAOUI N, Tardif JC, Waters DD, Pinto FJ, et al
    Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
    Eur Heart J. 2020 Aug 29. pii: 5898840. doi: 10.1093.
    PubMed     Abstract available


  176. HINDRICKS G, Potpara T, Dagres N, Arbelo E, et al
    2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2020 Aug 29. pii: 5899003. doi: 10.1093.
    PubMed    


  177. FERLINI M, Mauri S
    Variable rate of stroke after transcatheter aortic valve replacement with self-expandable valves: more doubts than certainties.
    Eur Heart J. 2020 Aug 18. pii: 5893661. doi: 10.1093.
    PubMed    


  178. THIELE H, Abdel-Wahab M, Desch S
    Stroke rates after transcatheter aortic valve replacement: does valve choice play a role?
    Eur Heart J. 2020 Aug 18. pii: 5893660. doi: 10.1093.
    PubMed    


    July 2020
  179. MENTE A, Dehghan M, Yusuf S
    Diet and health: the need for new and reliable approaches.
    Eur Heart J. 2020;41:2641-2644.
    PubMed    


    April 2020
  180. LINDE C
    Integrated care for atrial fibrillation: time for widespread use.
    Eur Heart J. 2020 Apr 13. pii: 5819644. doi: 10.1093.
    PubMed    


    February 2020
  181. HUANG HK, Liu PP, Hsu JY, Lin SM, et al
    Fracture risks among patients with atrial fibrillation receiving different oral anticoagulants: a real-world nationwide cohort study.
    Eur Heart J. 2020 Feb 1. pii: 5718429. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  182. GUNDLUND A, Olesen JB, Butt JH, Christensen MA, et al
    One-year outcomes in atrial fibrillation presenting during infections: a nationwide registry-based study.
    Eur Heart J. 2019 Dec 17. pii: 5680017. doi: 10.1093.
    PubMed     Abstract available


  183. BHARADWAJ A, Potts J, Mohamed MO, Parwani P, et al
    Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA.
    Eur Heart J. 2019 Dec 4. pii: 5652220. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  184. LUSCHER TF
    Optimizing heart failure management: anticoagulation, diuretic withdrawal, iron substitution, and novel inotropes.
    Eur Heart J. 2019;40:3579-3582.
    PubMed    


    October 2019
  185. GARGIULO G, Goette A, Tijssen J, Eckardt L, et al
    Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based rand
    Eur Heart J. 2019 Oct 25. pii: 5607287. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  186. WIJTVLIET EPJP, Tieleman RG, van Gelder IC, Pluymaekers NAHA, et al
    Nurse-led vs. usual-care for atrial fibrillation.
    Eur Heart J. 2019 Sep 23. pii: 5572602. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  187. SERRUYS PW, Takahashi K, Chichareon P, Kogame N, et al
    Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
    Eur Heart J. 2019;40:2595-2604.
    PubMed     Abstract available


    June 2019
  188. KOTECHA D, Castella M
    Is it time to treat post-operative atrial fibrillation just like regular atrial fibrillation?
    Eur Heart J. 2019 Jun 25. pii: 5523037. doi: 10.1093.
    PubMed    


  189. CONEN D, Alonso-Coello P, Douketis J, Chan MTV, et al
    Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery.
    Eur Heart J. 2019 Jun 25. pii: 5523034. doi: 10.1093.
    PubMed     Abstract available


  190. PIAZZA G, Hurwitz S, Galvin CE, Harrigan L, et al
    Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT).
    Eur Heart J. 2019 Jun 22. pii: 5521151. doi: 10.1093.
    PubMed     Abstract available


  191. KIM D, Yang PS, Yu HT, Kim TH, et al
    Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort.
    Eur Heart J. 2019 Jun 18. pii: 5520105. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  192. FRIBERG L, Andersson T, Rosenqvist M
    Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation.
    Eur Heart J. 2019 May 16. pii: 5490291. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  193. BONDE AN, Blanche P, Staerk L, Gerds TA, et al
    Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study.
    Eur Heart J. 2019 Apr 1. pii: 5424120. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  194. KHAN AA, Lip GYH
    Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?
    Eur Heart J. 2019 Jan 21. pii: 5298544. doi: 10.1093.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.